Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
20.86
-0.15 (-0.71%)
At close: May 22, 2026, 4:00 PM EDT
20.56
-0.30 (-1.42%)
After-hours: May 22, 2026, 7:52 PM EDT
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $2.61 billion as of May 22, 2026. Its market cap has increased by 61.96% in one year.
Market Cap
2.61B
Enterprise Value
2.50B
1-Year Change
61.96%
Ranking
Category
Stock Price
$20.86
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $2.61B, an increase of 233.65%. That is a compound annual growth rate of 21.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 2.61B | -26.65% |
| Dec 31, 2025 | 3.56B | 118.17% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alumis | 2.81B |
| Structure Therapeutics | 2.79B |
| Kailera Therapeutics | 2.74B |
| Tarsus Pharmaceuticals | 2.68B |
| IDEAYA Biosciences | 2.56B |
| Disc Medicine | 2.55B |
| Enliven Therapeutics | 2.53B |
| Mineralys Therapeutics | 2.46B |